Furthermore, sensitivity to ATM-mediated growth inhibition in lung cancer cells correlates directly with expression of PKCι and Par6 but not to other proposed ATM targets such as thioredoxin reductases [19]. This evidence concerns the gene PRDX5 and lung cancer.